welcome to DuchenneXchange
- a positively charged Duchenne muscular dystrophy community.- join today!
- login
Abstracts & Posters
P4.1 Puberty is delayed or absent in Duchenne Muscular Dystrophy boys on chronic glucocorticoid therapy
source: Neuromuscular Disorders
year: 2011
authors: M.M. Rutter, S.R. Rose, J. Collins, H. Sucherew, B.L. Wong, I. Rybalsky
summary/abstract:Chronic glucocorticoids (GCs) are standard therapy and slow disease progression in Duchenne Muscular Dystrophy (DMD). However, GCs cause adverse endocrine effects, including pubertal delay, growth failure and osteoporosis. Absent/delayed puberty is an important problem in DMD which, in turn, negatively impacts bone health, growth, self esteem and muscle strength. The prevalence in DMD is unknown, and it is frequently under-recognized and untreated.
The objective is to determine the prevalence of absent /delayed puberty in DMD boys on GC therapy.
organisation: Cincinnati Children’s Hospital Medical Center, USADOI: 10.1016/j.nmd.2011.06.966
read more
rareRelated
-
Deflazacort Expanded Access Program for Children, Adolescents and Adults With Duchenne Muscular DystrophyThe expanded access program will provide...
-
Finding the Optimum Regimen for Duchenne Muscular DystrophyThe Finding the Optimum Regimen for Duch...
-
A Comparison of the Effects of Deflazacort and Prednisone Versus Placebo on Timed Functional Tests in Boys with Duch...Objective: To describe the timed motor ...
-
Delayed Puberty in Duchenne Muscular Dystrophy: For ParentsThis information sheet is about delayed ...
-
Corticosteroids for Duchenne Muscular DystrophyNeurologists from the American Academy o...
-
Effect of Deflazacort and Prednisone on Muscle Enzymes in the Treatment of Duchenne Muscular DystrophyObjective: To describe the effects of d...
-
Long-Term Outcome of Interdisciplinary Management of Patients with Duchenne Muscular Dystrophy Receiving Daily Gluco...OBJECTIVE: To evaluate clinical outcome...